Trends and Drug Launches Impacting the US Health Care Market in 2021-2022
March 31st 2022While the pandemic will have lasting impacts on the US health care market, much of it has bounced back and returned to normal, said Doug Long, MBA, of IQVIA, during the Thursday keynote at the Academy of Managed Care Pharmacy annual meeting.
Read More
What We’re Reading: CMS Hospice Payment Rate Rule; COVID-19 Funding; FDA Votes on ALS Treatment
March 31st 2022CMS-1773-P will establish a budget-neutral payment policy to smooth year-to-year changes in the hospice wage index; President Joe Biden pushes for $22 billion in COVID-19 funding from Congress; an FDA advisory panel said there is not enough evidence supporting the efficacy of the amyotrophic lateral sclerosis (ALS) treatment AMX0035.
Read More
Severe Uncontrolled Asthma Results in Higher Economic Burden Despite Treatment With Biologics
March 31st 2022Patients with severe asthma continue to have residual disease despite initiating treatment with biologics, and severe uncontrolled asthma is associated with higher economic burden compared with controlled asthma, according to 2 posters.
Read More
Contributor: COVID-19 Pandemic’s Impact on Health Care System Documented in FAIR Health Report
March 31st 2022A new FAIR Health white paper containing the fifth annual edition of FH Healthcare Indicators and FH Medical Price Index was released, showing a dramatic increase in telehealth utilization from 2019 to 2020.
Read More
What We’re Reading: Epilepsy Drug Approval; Free COVID-19 Testing Ends; EPA Sued
March 28th 2022The FDA approved a drug to treat a rare form of childhood epilepsy; uninsured Americans will no longer have access to free COVID-19 tests; a conservation group is suing the Environmental Protection Agency (EPA) over failure to protect rivers from pollution.
Read More
Infliximab Biosimilar Maintains Outcomes, Remission Status After Switch From Originator
March 24th 2022Patients switched from the originator product maintained their clinical outcomes and remissions status while biologic-naïve patients recorded positive responses and remission outcomes after initiating infliximab-dyyb.
Read More
Colette Romero on the Financial Impact of EoE and Health Equity Implications
March 18th 2022Eosinophilic esophagitis (EoE) is triggered by food and in this interview, Colette Romero, whose son has the disease, discusses the financial implications for families, including equity considerations.
Read More
Looking Beyond COVID-19, US Health Officials Outline Next Steps to Fight Disease
March 2nd 2022From one-stop testing and treatment sites to boosting research and surveillance, Biden administration health officials expanded on the COVID-19 plan the president announced in his State of the Union address Tuesday night, but the plan will require additional funding from Congress.
Read More
Report: Economic Burden of Rare Diseases Is 10 Times Higher Than Mass Market Diseases
March 2nd 2022The economic burden of rare diseases based on direct, indirect, and mortality-related costs is 10 times greater than the burden for mass market diseases, such as diabetes and cardiovascular disease, and this burden increases when no treatment is available.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Read More
Experts Discuss How Employers Can Take on HSA HDHP Challenges While Encouraging Value-Based Care
February 20th 2022Speaking during a webinar presented by the National Alliance of Healthcare Purchaser Coalitions, experts weighed the pros and cons of employer high-deductible health plans (HDHPs) and outlined steps to address challenges raised.
Read More